ethyl 3-(2,4-dichlorobenzyl)-2-oxoindoline-3-carboxylate

ID: ALA4644318

Chembl Id: CHEMBL4644318

PubChem CID: 16210741

Max Phase: Preclinical

Molecular Formula: C18H15Cl2NO3

Molecular Weight: 364.23

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CCOC(=O)C1(Cc2ccc(Cl)cc2Cl)C(=O)Nc2ccccc21

Standard InChI:  InChI=1S/C18H15Cl2NO3/c1-2-24-17(23)18(10-11-7-8-12(19)9-14(11)20)13-5-3-4-6-15(13)21-16(18)22/h3-9H,2,10H2,1H3,(H,21,22)

Standard InChI Key:  DWBPCKNPUQQHND-UHFFFAOYSA-N

Associated Targets(Human)

ADCY8 Tchem Adenylate cyclase type VIII (190 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADCY1 Tchem Brain adenylate cyclase 1 (372 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADCY2 Tchem Adenylate cyclase type II (148 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADCY5 Tchem Adenylate cyclase type V (137 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 364.23Molecular Weight (Monoisotopic): 363.0429AlogP: 3.99#Rotatable Bonds: 4
Polar Surface Area: 55.40Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 12.76CX Basic pKa: CX LogP: 4.65CX LogD: 4.65
Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.66Np Likeness Score: -0.35

References

1. Weng Z, Xu G, Chen D, Yang Y, Song G, Shen W, Zhang S, Wang L, Yang W, Zuo Z..  (2020)  Discovery of a potent and selective adenylyl cyclase type 8 agonist by docking-based virtual screening.,  30  (2): [PMID:31776060] [10.1016/j.bmcl.2019.126823]
2. Xu G,Yang Y,Yang Y,Song G,Li S,Zhang J,Yang W,Wang LL,Weng Z,Zuo Z.  (2020)  The discovery, design and synthesis of potent agonists of adenylyl cyclase type 2 by virtual screening combining biological evaluation.,  191  [PMID:32105982] [10.1016/j.ejmech.2020.112115]

Source